16 September 2026 editorial review · Item
MicroTech LinX: review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: MicroTech LinX
Scope and findings: Added in the second discovery pass. A small standalone CGM with15-day wear. The current EU manual covers diabetes from age2, with age-specific insertion sites. Manufacturer accuracy claims are not treated as head-to-head evidence. Numerical claims are tied to the cited product specifications or named study, and editorial scores do not represent measured comparative performance.
Primary sources checked:
- MicroTech LinX product specifications
- LinX EU user guide V09,24March2026
- MicroTech WHX Miami2026 product update
Limits: Scope is the specific claims documented in the new record. Local stock, payer rules, every hardware variant and unreported head-to-head outcomes are not verified. Regulatory status, manufacturer marketing and clinical performance are distinct.